Introduction to Investors: EIT Health has a strong network of investors with whom we can provide fast access particularly for companies working within the areas of neurological diseases, immune and inflammatory diseases, gene editing metabolic diseases, implantable devices, cardiovascular diseases, digital therapeutics, in silico trials, mental health and telemonitoring in severely chronic patients